APA (7th ed.) Citation

Y, V., G, G., M, H., AH, L., & H, D. (2019). Evaluation of the potential for QTc prolongation with avelumab. Cancer chemotherapy and pharmacology, 84(5), 1017. https://doi.org/10.1007/s00280-019-03925-z

Chicago Style (17th ed.) Citation

Y, Vugmeyster, Güzel G, Hennessy M, Loos AH, and Dai H. "Evaluation of the Potential for QTc Prolongation with Avelumab." Cancer Chemotherapy and Pharmacology 84, no. 5 (2019): 1017. https://doi.org/10.1007/s00280-019-03925-z.

MLA (9th ed.) Citation

Y, Vugmeyster, et al. "Evaluation of the Potential for QTc Prolongation with Avelumab." Cancer Chemotherapy and Pharmacology, vol. 84, no. 5, 2019, p. 1017, https://doi.org/10.1007/s00280-019-03925-z.